Event Highlights - September 8, 2026
NLSDays 2026: 3 x Voices from the exhibition floor
Our journalist Alexandra Hoegberg took the pulse of this year's NLSDays – the anticipation in the air, and the experiences and insights being shared.
Collaboration - September 8, 2026
HeartBeat.bio and Cubase Bio partner to advance 3D spatial transcriptomics
Vienna-based HeartBeat.bio and Stockholm-based Cubase Bio have been awarded roughly EUR 1 million in Eurostars funding to develop a 3D spatial profiling method for studying myocardial fibrosis and heart failure, combining human cardiac organoids with true 3D spatial transcriptomics technology.
Financing - September 8, 2026
BII allocates EUR 8 million to six promising life science companies
BioInnovation Institute (BII) is providing EUR 1.3 million each to six Copenhagen-based companies working across cancer therapy, inflammatory disease, and sustainability, bringing its total investment in each to EUR 1.8 million.
Science News - September 8, 2026
“Our study is an example of the shift toward targeting cancer metabolism inside the cell”
Researchers at the University of Gothenburg have developed a treatment for acute myeloid leukemia that forces cancer cells to run at full throttle while cutting off their energy supply, driving them to burn out and die from the stress. The first study in mice shows highly promising results.
Collaboration - September 8, 2026
Klaria and RTHS partner to enable earlier detection and treatment of migraine
Klaria has entered a collaboration agreement with RTHS to combine RTHS's sensor-based measurements of blood flow dynamics with Klaria's approved migraine treatment, aiming to detect migraine attacks before symptoms set in.
SwedenBIO - September 8, 2026
Why we are mapping Swedish medtech innovation
When people think of life science innovation, they often think of new medicines. Yet many of the innovations transforming healthcare today – from AI-powered diagnostics to robotic surgery and remote patient monitoring – are driven by medtech companies. With my own multiyear background in the medtech industry, this section of life science has a special place in my heart.
